![As COVID-19 demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output by 50% | Fierce Pharma As COVID-19 demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output by 50% | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1607010503/Syringes.jpg/Syringes.jpg?VersionId=E7L3F7ScKwKaOXlVqffBV4H4AevyioCm)
As COVID-19 demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output by 50% | Fierce Pharma
![Expert's Opinion: Three questions about Prefilled Syringes and Parenteral Contract Manufacturing | World Pharma Today Expert's Opinion: Three questions about Prefilled Syringes and Parenteral Contract Manufacturing | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/articles/22737/Dual-Chamber-Syringe-Vetter-Lyo-Ject.jpg)
Expert's Opinion: Three questions about Prefilled Syringes and Parenteral Contract Manufacturing | World Pharma Today
![SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: Drug & Packaging Ensure Safety, Compatibility & Stability SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: Drug & Packaging Ensure Safety, Compatibility & Stability](https://d2akihtr51eb46.cloudfront.net/wp-content/uploads/2018/05/Aptar.jpg)
SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: Drug & Packaging Ensure Safety, Compatibility & Stability
![SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing - Product Differentiation Is Critical SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing - Product Differentiation Is Critical](https://d2akihtr51eb46.cloudfront.net/wp-content/uploads/2014/05/Unilife.jpg)